{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:36:10Z","timestamp":1782959770016,"version":"3.54.5"},"reference-count":29,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/gxeb5902","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:18:36Z","timestamp":1732853916000},"page":"6519-6527","source":"Crossref","is-referenced-by-count":5,"title":["Zoledronic acid improves periodontal health, reduces serum inflammation, and enhances bone metabolism in postmenopausal osteoporosis complicated by periodontitis"],"prefix":"10.62347","volume":"16","author":[{"given":"Ge","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Bhatnagar A and Kekatpure AL. Postmenopausal osteoporosis: a literature review. Cureus 2022; 14: e29367.","DOI":"10.7759\/cureus.29367"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"11795441211072471","DOI":"10.1177\/11795441211072471","article-title":"Prevalence of osteoporosis among Iranian postmenopausal women: a systematic review and meta-analysis","volume":"15","author":"Eghbali","year":"2022","unstructured":"Eghbali T, Abdi K, Nazari M, Mohammadnejad E and Gheshlagh RG. Prevalence of osteoporosis among Iranian postmenopausal women: a systematic review and meta-analysis. Clin Med Insights Arthritis Musculoskelet Disord 2022; 15: 11795441211072471.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/17512433.2021.1851192","article-title":"Pharmacological management of postmenopausal osteoporosis: a level I evidence based - expert opinion","volume":"14","author":"Migliorini","year":"2021","unstructured":"Migliorini F, Colarossi G, Baroncini A, Eschweiler J, Tingart M and Maffulli N. Pharmacological management of postmenopausal osteoporosis: a level I evidence based - expert opinion. Expert Rev Clin Pharmacol 2021; 14: 105-119.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6874-10-12","article-title":"Association of physical exercise and calcium intake with bone mass measured by quantitative ultrasound","volume":"10","author":"Dionyssiotis","year":"2010","unstructured":"Dionyssiotis Y, Paspati I, Trovas G, Galanos A and Lyritis GP. Association of physical exercise and calcium intake with bone mass measured by quantitative ultrasound. BMC Womens Health 2010; 10: 12.","journal-title":"BMC Womens Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4103\/jehp.jehp_945_20","article-title":"Prevalence of primary osteoporosis and low bone mass in postmenopausal women and related risk factors","volume":"10","author":"Hemmati","year":"2021","unstructured":"Hemmati E, Mirghafourvand M, Mobasseri M, Shakouri SK, Mikaeli P and Farshbaf-Khalili A. Prevalence of primary osteoporosis and low bone mass in postmenopausal women and related risk factors. J Educ Health Promot 2021; 10: 204.","journal-title":"J Educ Health Promot"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/prd.12422","article-title":"Osteoporosis and periodontal diseases - an update on their association and mechanistic links","volume":"89","author":"Yu","year":"2022","unstructured":"Yu B and Wang CY. Osteoporosis and periodontal diseases - an update on their association and mechanistic links. Periodontol 2000 2022; 89: 99-113.","journal-title":"Periodontol 2000"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1120457","DOI":"10.3389\/fphar.2023.1120457","article-title":"Overview on postmenopausal osteoporosis and periodontitis: the therapeutic potential of phytoestrogens against alveolar bone loss","volume":"14","author":"PA","year":"2023","unstructured":"Jayusman PA, Nasruddin NS, Baharin B, Ibrahim N’, Ahmad Hairi H and Shuid AN. Overview on postmenopausal osteoporosis and periodontitis: the therapeutic potential of phytoestrogens against alveolar bone loss. Front Pharmacol 2023; 14: 1120457.","journal-title":"Front Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"DM","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF and Cummings SR; HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007; 356: 1809-1822.","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1084453","DOI":"10.3389\/fphar.2023.1084453","article-title":"Identifying therapeutic biomarkers of zoledronic acid by metabolomics","volume":"14","author":"Li","year":"2023","unstructured":"Li X, Wang ZY, Ren N, Wei ZY, Hu WW, Gu JM, Zhang ZL, Yu XT and Wang C. Identifying therapeutic biomarkers of zoledronic acid by metabolomics. Front Pharmacol 2023; 14: 1084453.","journal-title":"Front Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1177\/15353702211011052","article-title":"Zoledronic acid modulates osteoclast apoptosis through activation of the NF-kappaB signaling pathway in ovariectomized rats","volume":"246","author":"Cheng","year":"2021","unstructured":"Cheng YT, Liao J, Zhou Q, Huo H, Zellmer L, Tang ZL, Ma H, Hong W and Liao DJ. Zoledronic acid modulates osteoclast apoptosis through activation of the NF-kappaB signaling pathway in ovariectomized rats. Exp Biol Med (Maywood) 2021; 246: 1727-1739.","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1515\/dmpt-2020-0187","article-title":"Effect of zoledronic acid on bone nanocomposites organization and prevention of bone mineral density loss in ovariectomized rats","volume":"36","author":"Kostyshyn","year":"2021","unstructured":"Kostyshyn NM, Gzhegotskyi MR, Kostyshyn LP and Mudry SI. Effect of zoledronic acid on bone nanocomposites organization and prevention of bone mineral density loss in ovariectomized rats. Drug Metab Pers Ther 2021; 36: 239-245.","journal-title":"Drug Metab Pers Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/cap.10262","article-title":"05% zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type-2 diabetes mellitus-a randomized split-mouth clinical trial","volume":"14","author":"Raj","year":"2024","unstructured":"Raj SC, Mishra AK, Mohanty D, Katti N, Pattnaik S, Patra L and Pattanaik A. Comparative evaluation of the clinical and radiographic efficacy of 0.05% zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type-2 diabetes mellitus-a randomized split-mouth clinical trial. Clin Adv Periodontics 2024; 14: 211-222.","journal-title":"Clin Adv Periodontics"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.5051\/jpis.2001100055","article-title":"The effects of zoledronic acid on the progression of experimental periodontitis in rats: histological and microtomographic analyses","volume":"51","author":"Leite de Marcelos","year":"2021","unstructured":"Leite de Marcelos PGC, Perez DEDCP, Soares DM, de Araujo SS, Evencio LB, Pontual MLDA and Ramos-Perez FMM. The effects of zoledronic acid on the progression of experimental periodontitis in rats: histological and microtomographic analyses. J Periodontal Implant Sci 2021; 51: 264-275.","journal-title":"J Periodontal Implant Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jre.12464","article-title":"Patients with chronic periodontitis present increased risk for osteoporosis: a population-based cohort study in Taiwan","volume":"52","author":"Mau","year":"2017","unstructured":"Mau LP, Kuan YC, Tsai YC, Lin JJ, Huynh-Ba G, Weng PW, Shieh YS, Cheng WC and Huang RY. Patients with chronic periodontitis present increased risk for osteoporosis: a population-based cohort study in Taiwan. J Periodontal Res 2017; 52: 922-929.","journal-title":"J Periodontal Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cden.2016.11.002","article-title":"Normal oral flora and the oral ecosystem","volume":"61","author":"Samaranayake","year":"2017","unstructured":"Samaranayake L and Matsubara VH. Normal oral flora and the oral ecosystem. Dent Clin North Am 2017; 61: 199-215.","journal-title":"Dent Clin North Am"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11914-016-0330-3","article-title":"Osteoporosis and periodontitis","volume":"14","author":"Wang","year":"2016","unstructured":"Wang CJ and McCauley LK. Osteoporosis and periodontitis. Curr Osteoporos Rep 2016; 14: 284-291.","journal-title":"Curr Osteoporos Rep"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Sun J, Rahmati M, Xie W, Yang G, Ji B, Yon DK, Lee SW, Gyasi RM, Lopez Sanchez GF, Soysal P, Koyanagi A, Smith L, Shin JI and Li Y. Efficacy and safety of zoledronic acid in the treatment of osteoporosis: a meta-analysis of randomized controlled trials. Heliyon 2024; 10: e33871.","DOI":"10.1016\/j.heliyon.2024.e33871"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/GME.0000000000001393","article-title":"Improved periodontal disease and prevention of tooth loss in osteoporosis patients receiving once-yearly zoledronic acid: a randomized clinical trial","volume":"26","author":"Taguchi","year":"2019","unstructured":"Taguchi A, Shiraki M, Tanaka S, Ohshige H and Nakamura T. Improved periodontal disease and prevention of tooth loss in osteoporosis patients receiving once-yearly zoledronic acid: a randomized clinical trial. Menopause 2019; 26: 1277-1283.","journal-title":"Menopause"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"961941","DOI":"10.3389\/fphar.2022.961941","article-title":"How zoledronic acid improves osteoporosis by acting on osteoclasts","volume":"13","author":"Wang","year":"2022","unstructured":"Wang B, Zhan Y, Yan L and Hao D. How zoledronic acid improves osteoporosis by acting on osteoclasts. Front Pharmacol 2022; 13: 961941.","journal-title":"Front Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/ijmm.2016.2582","article-title":"Zoledronic acid suppresses transforming growth factor-beta-induced fibrogenesis by human gingival fibroblasts","volume":"38","author":"Komatsu","year":"2016","unstructured":"Komatsu Y, Ibi M, Chosa N, Kyakumoto S, Kamo M, Shibata T, Sugiyama Y and Ishisaki A. Zoledronic acid suppresses transforming growth factor-beta-induced fibrogenesis by human gingival fibroblasts. Int J Mol Med 2016; 38: 139-147.","journal-title":"Int J Mol Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/odi.13531","article-title":"Associations between osteoporosis and risk of periodontitis: a pooled analysis of observational studies","volume":"27","author":"Xu","year":"2021","unstructured":"Xu S, Zhang G, Guo JF and Tan YH. Associations between osteoporosis and risk of periodontitis: a pooled analysis of observational studies. Oral Dis 2021; 27: 357-369.","journal-title":"Oral Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/154405910608500704","article-title":"Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis","volume":"85","author":"Lerner","year":"2006","unstructured":"Lerner UH. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res 2006; 85: 596-607.","journal-title":"J Dent Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.joen.2023.08.010","article-title":"Zoledronic acid modulates cytokine expression and mitigates bone loss during the development of induced apical periodontitis in a mice model","volume":"49","author":"Maia","year":"2023","unstructured":"Maia CA, Chaves HGDS, Benetti F, de Menezes GB, Antunes MM, Pinto KP, Silva EJNL, Sobrinho APR and Tavares WLF. Zoledronic acid modulates cytokine expression and mitigates bone loss during the development of induced apical periodontitis in a mice model. J Endod 2023; 49: 1522-1528.","journal-title":"J Endod"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1007\/s00402-021-03858-4","article-title":"Effectiveness and safety of percutaneous kyphoplasty combined with zoledronic acid in treatment of osteoporotic vertebral compression fractures: a meta-analysis","volume":"142","author":"Zhuang","year":"2022","unstructured":"Zhuang M, Cai B and Wang F. Effectiveness and safety of percutaneous kyphoplasty combined with zoledronic acid in treatment of osteoporotic vertebral compression fractures: a meta-analysis. Arch Orthop Trauma Surg 2022; 142: 2435-2443.","journal-title":"Arch Orthop Trauma Surg"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Huang K, Tang X and Tang F. Combined chemotherapy of zoledronic acid and pamidronate in the treatment of bone metastases from nonsmall cell lung cancer and the effects on pain stress and bone metabolic indices. Drug Dev Res 2024; 85: e22147.","DOI":"10.1002\/ddr.22147"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcph.2181","article-title":"Efficacy and safety of annual infusion of zoledronic acid and weekly oral alendronate in the treatment of primary osteoporosis: a meta-analysis","volume":"63","author":"Wang","year":"2023","unstructured":"Wang Q, Yu Q, Zeng P and Ai W. Efficacy and safety of annual infusion of zoledronic acid and weekly oral alendronate in the treatment of primary osteoporosis: a meta-analysis. J Clin Pharmacol 2023; 63: 455-465.","journal-title":"J Clin Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jor.2023.07.019","article-title":"Zoledronic acid for osteoporosis after distal radius fracture surgery: prospective longitudinal study","volume":"43","author":"Yoshizawa","year":"2023","unstructured":"Yoshizawa S, Shintaku T, Ishii H, Sakamoto M, Musha Y and Ikegami H. Zoledronic acid for osteoporosis after distal radius fracture surgery: prospective longitudinal study. J Orthop 2023; 43: 109-114.","journal-title":"J Orthop"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.2147\/DDDT.S328858","article-title":"Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients","volume":"15","author":"CF","year":"2021","unstructured":"Huang CF, Shiao MS and Mao TY. Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients. Drug Des Devel Ther 2021; 15: 3711-3715.","journal-title":"Drug Des Devel Ther"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fphar.2020.00456","article-title":"Cost-effectiveness of zoledronic acid versus oral alendronate for postmenopausal osteoporotic women in China","volume":"11","author":"You","year":"2020","unstructured":"You R, Zhang Y, Wu DB, Liu J, Qian X, Luo N and Mori T. Cost-effectiveness of zoledronic acid versus oral alendronate for postmenopausal osteoporotic women in China. Front Pharmacol 2020; 11: 456.","journal-title":"Front Pharmacol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/11\/ajtr0160640.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:55Z","timestamp":1766023015000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/11\/ajtr0160640.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/gxeb5902","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}